Share chart Lucira Health, Inc.
Extended chart
Simple chart
About
Lucira Health, Inc., медицинская технологическая компания, специализируется на разработке и коммерциализации наборов для тестирования на инфекционные заболевания. Он разрабатывает платформу для тестирования, которая предоставляет услуги молекулярного тестирования. Компания предлагает набор для тестирования LUCIRA COVID-19 All-In-One, который обеспечивает результат COVID-19; и разрабатывает наборы для тестирования вирусов гриппа A и B. Компания ранее называлась DiAssess Inc. и сменила название на Lucira Health, Inc. в январе 2020 года. Lucira Health, Inc.
More details| EV/EBITDA | -0.7039 |
|---|---|
| EBITDA | -0.0059 |
| Цена ао | 0.0339 |
| P/S | 3.01 |
| Сайт | https://www.lucirahealth.com |
| P/BV | 1.48 |
| Число акций ао | 0.04022 млрд |
| Выручка | 0.000269 |
| Див.доход ао | 0 |
| ISIN | US54948U1051 |
| Валюта | usd |
| IPO date | 2021-02-05 |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Валюта отчета | usd |
| Change price per day: | 0% (0.0339) |
|---|---|
| Change price per week: | 0% (0.0339) |
| Change price per month: | 0% (0.0339) |
| Change price per 3 month: | 0% (0.0339) |
| Change price per half year: | 0% (0.0339) |
| Change price per year: | 0% (0.0339) |
| Change price per 3 year: | -99.45% (6.13) |
| Change price per year to date: | 0% (0.0339) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Eclipse Ventures, LLC | 6223795 | 15.52 |
| EPIQ Capital Group, LLC | 725675 | 1.81 |
| Vanguard Group, Inc. (The) | 623488 | 1.55 |
| Citigroup Inc. | 436840 | 1.09 |
| Balyasny Asset Management LLC | 271030 | 0.68 |
| Morgan Stanley | 207755 | 0.52 |
| Papp (L. Roy) & Associates | 150699 | 0.38 |
| Bridgeway Capital Management, Inc. | 110500 | 0.28 |
| Geode Capital Management, LLC | 95621 | 0.24 |
| Consilio Wealth Advisors, LLC | 90199 | 0.22 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Erik T. Engelson | Pres, CEO & Director | 1.05M | 1960 (64 years) |
| Greg Chodaczek | Investor Relations | N/A | |
| Mr. Kevin Walter Collins | Chief Revenue Officer | 740.75k | 1977 (47 years) |
| Mr. Ghazi Kashmolah | Chief Quality Officer & Exec. VP of Regulatory Affairs | 603.47k | 1961 (63 years) |
| Mr. Tony Allen | Chief Operations Officer | N/A | 1963 (61 year) |
| Dr. Nadine Greiner Ph.D. | Chief HR Officer | N/A | |
| Mr. Richard Narido | Chief Financial Officer | ||
| Mr. Daniel V. George | Treasurer | 1970 (54 years) |
Address: United States, EmeryVille, CA , 1412 62nd Street - open in Google maps, open in Yandex maps
Website: https://www.lucirahealth.com
Website: https://www.lucirahealth.com
